Halozyme Therapeutics is entering a powerful earnings inflection. FY25 revenue grew 38% to $1.397 billion. Check out why I am bullish on HALO stock.

Metabolomics-Derived Pathway Scores Outperform Inflammatory Protein Markers-Delivering Risk Prediction Where Proteomics Falls ShortMORRISVILLE, N.C., Feb. 17, 2026 /PRNewswire/ -- Metabolon ...

Innate immunity is a foundational field in immunology, critical for understanding how organisms sense and respond to danger, be it pathogens or sterile ...

Red blood cells (RBCs), traditionally regarded as passive oxygen carriers, are now recognized as highly dynamic regulators of immune and vascular ...

With pill fatigue on the rise and modern diets falling short, wellness editor Emilie Lavinia tests whether a holistic liquid ...

Researchers at Indiana University Bloomington have identified a chemical molecule that disables a bacterial immune system, ...

This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...

An innovative approach supercharges the innate immune system to provide a first line of defence against respiratory infections.

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, ...

TermLifeCompare.com’s AI Architecture Engine analyzes carrier guides to provide clear product insights and bring ...

From birth-month signatures to global climate gradients, emerging evidence indicates that seasonal light, temperature, and ...